货号:A198464
同义名:
2-羟基苯甲酸钠
/ Salicylic acid sodium salt; 2-Hydroxybenzoic acid sodium salt
Sodium Salicylate 是一种抗炎化合物,可抑制 COX-2 活性和 NF-κB 的激活,还能降低炎症基因表达并促进老化肌肉的修复,适用于炎症和衰老相关疾病的研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
| Sodium Salicylate | ✔ | 95% | |||||||||||||||||
| Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
| Andrographolide | ✔ | 98+% | |||||||||||||||||
| Curcumin | ✔ | Nrf2,HDAC | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Sodium 2-Hydroxybenzoate (Sodium Salicylate) inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation[3]. Sodium salicylate and aspirin also inhibited NF-kappa B-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells[4]. Sodium salicylate effectively inhibited TNF-alpha-induced upregulation of NF-kappaB, ICAM-1 expression, in-vitro migration and invasion in human melanoma cells, indicating that non-steroidal anti-inflammatory drugs may be a useful therapeutic approach to oppose inflammation-induced melanoma invasion and metastasis in vivo[5]. PC12 cells were treated with different concentrations of sodium salicylate (1-20 mM). Higher concentrations (10-20 mM) killed PC12 cells in a dose-dependent manner. A decreased NF-kappaB activity after sodium salicylate treatment by electrophoretic mobility shift assay (EMSA)[6]. In the RAW264.7 macrophage cell line, suprapharmacological concentrations of sodium salicylate exert a potent inhibitory effect on LPS-induced cytokine gene induction but appear to accomplish this by interfering with NF-kappaB-independent pathways of activation[7]. Moreover, salicylate significantly improved retinal function, as well as reduced TNFα and SOCS3-induced insulin resistance in all samples[8]. |
| Concentration | Treated Time | Description | References | |
| Mouse diaphragm muscle cells | 5 mM | 10 minutes | To study the effect of sodium salicylate on the quantal content of endplate potentials (e.p.ps). Results showed that sodium salicylate increased the quantal content of e.p.ps, and this effect was dependent on the concentration of [Ca2+]. | Br J Pharmacol. 1989 Aug;97(4):1239-45 |
| Mouse diaphragm muscle cells | 10 mM | 10-15 minutes | To study the effect of sodium salicylate on spontaneous transmitter release at the mouse neuromuscular junction. Results showed that at 36°C, sodium salicylate increased the frequency of miniature endplate potentials (m.e.p.ps), and this effect was insensitive to [Mg2+] and independent of the presence of [Ca2+]. | Br J Pharmacol. 1989 Aug;97(4):1239-45 |
| Inferior colliculus neurons | 350 mg/L | 2-4 hours | To investigate the effect of sodium salicylate on spontaneous firing of inferior colliculus neurons, results showed that sodium salicylate significantly reduced the spontaneous firing rate in most neurons | iScience. 2024 Apr 9;27(5):109691 |
| Mouse cochlear inner hair cells (IHCs) | 10-20 mM | 48 hours | To study the damaging effects of high concentrations of sodium salicylate on inner hair cells, found that 10-20 mmol/L salicylate caused significant damage to IHCs. | Neurosci Bull. 2022 Jan;38(1):69-80 |
| Mouse cochlear inner hair cells (IHCs) | 1-5 mM | 48 hours | To investigate the effects of sodium salicylate on calcium currents and exocytosis in inner hair cells, found that 1-5 mmol/L salicylate did not affect the exocytosis of IHCs but increased the peak amplitude of calcium currents. | Neurosci Bull. 2022 Jan;38(1):69-80 |
| Pseudomonas aeruginosa PAO1 ΔlasR ΔrhlR | 10 mM | 48 hours | To evaluate the effect of NaSa on biofilm formation of QS-deficient strain, results showed that NaSa had no significant effect on biofilm formation of PAO1 ΔlasR ΔrhlR. | Int J Mol Sci. 2021 Jan 21;22(3):1060 |
| Pseudomonas aeruginosa PAO1 wt | 10 mM | 48 hours | To evaluate the effect of NaSa on biofilm formation of PAO1 wt, results showed that NaSa significantly reduced biofilm biomass. | Int J Mol Sci. 2021 Jan 21;22(3):1060 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Anesthetized and awake mice | Intraperitoneal injection | 250 mg/kg | Single injection | To investigate the effect of sodium salicylate on spontaneous and sound-evoked activity in the inferior colliculus of mice, results showed that sodium salicylate significantly reduced spontaneous firing and improved the detection of amplitude-modulated sounds | iScience. 2024 Apr 9;27(5):109691 |
| Mice | NaSal-induced hyperacusis and anxiety-like behaviors model | Intraperitoneal injection | 300 mg/kg | Single injection | To investigate the neural mechanisms underlying NaSal-induced hyperacusis and anxiety-like behaviors | Commun Biol. 2024 Oct 18;7(1):1346 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
6.25mL 1.25mL 0.62mL |
31.23mL 6.25mL 3.12mL |
62.46mL 12.49mL 6.25mL |
|
| CAS号 | 54-21-7 |
| 分子式 | C7H5NaO3 |
| 分子量 | 160.1 |
| SMILES Code | OC1=CC=CC=C1C([O-])=O.[Na+] |
| MDL No. | MFCD00002440 |
| 别名 | 2-羟基苯甲酸钠 ;Salicylic acid sodium salt; 2-Hydroxybenzoic acid sodium salt; Magsalyl; Kerosal; Kerasalicyl |
| 运输 | 蓝冰 |
| InChI Key | ABBQHOQBGMUPJH-UHFFFAOYSA-M |
| Pubchem ID | 16760658 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 105 mg/mL(655.84 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(624.61 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1